ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials.

Greg Fulcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.